NorthWest Biotherapeutics Inc (NWBO)

[AllSheWrote]

Absolutely devastating.

Adam Feuerstein ✡️
@adamfeuerstein
$NWBO announced UK submission two years ago, and not a single substantive update from management since. Two years (!!) of silence. The absurdity of it all. Have UK regulators rejected DCVax, yet the company buries material news? Hello, @SECEnfDirector? Perhaps you'll investigate.
10:15 AM · Dec 19, 2025 - 12.3K Views

Adam Feuerstein ✡️
@adamfeuerstein
Dec 19, 2025
On, Dec. 29, $NWBO is holding its annual meeting, where it is seeking shareholder ok to increase its authorized share count by 900 million shares, from 1.7 billion to 2.6 billion.
No doubt, management will get the votes it needs.
Northwest Bio has run out of shares to sell, so it needs more!
Over the past two years, while management has said nothing about the DCVax review process or a UK decision, the company has issued/sold ~400M shares.
Now, it wants another 900 million shares to sell.

Adam Feuerstein ✡️
@adamfeuerstein
Dec 19, 2025
Over the past two years, $NWBO's stock price has fallen from 80 cents to 24 cents per share.
Its total liabilities have increased from $69M to $126M; and its short- and long-term debt has grown from $34M to $62M.

Adam Feuerstein ✡️
@adamfeuerstein
Dec 19, 2025
$NWBO management has known about the failure of DCVax's ph3 study in glioblastoma since 2015 - a full decade ago. To this day, it pretends the study was a success.
In some twisted way, you almost have to respect a company that can masquerade its clinical failure for a decade, all the while selling stock and paying management massive salaries.
This is great bit of trivia: Northwest Bio has not treated a single patient in a DCVax clinical trial since the failure of its Ph3 study in 2015. I'm not even sure the company would be allowed to conduct another clinical trial at this point.
Happy Holidays!